Skip to main content

Table 1 Clinical characteristics of colorectal cancer, adenomatous polyp, and control groups

From: Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study

Parameters Colorectal cancer group
(n = 186)
Adenomatous polyp group
(n = 132)
Control group
(n = 108)
p-value
Age (years) 54.56 ± 12.18 52.55 ± 12.16 53.34 ± 14.18 0.369
Male (%) 111 (59.7%) 79 (59.8%) 65 (60.2%) 0.996
WBC (109/L) 6.77 ± 1.64a 6.32 ± 1.61 6.23 ± 1.02c 0.003
RBC (1012/L) 4.42 ± 0.63a 4.78 ± 0.72 4.73 ± 0.42c < 0.001
Hb (g/L) 121.27 ± 23.07a 132.12 ± 20.03b 142.47 ± 11.80c < 0.001
Neutrophil (109/L) 3.92 ± 1.26a 3.57 ± 1.26 3.40 ± 0.79c < 0.001
Lymphocyte (109/L) 1.99 ± 0.58 1.99 ± 0.60b 2.18 ± 0.51c 0.010
Monocyte (109/L) 0.53 ± 0.19 0.50 ± 0.17b 0.45 ± 0.15c 0.001
Platelet count (109/L) 279.80 ± 80.56a 223.89 ± 42.59b 207.83 ± 37.40c < 0.001
MPV (fl) 8.48 ± 1.10a 8.83 ± 0.90 8.98 ± 0.77c < 0.001
MPV/PC 0.0330 ± 0.0112a 0.0411 ± 0.0112b 0.0447 ± 0.0096c < 0.001
NLR 1.98 (1.50–2.51)a 1.67 (1.37–2.27)b 1.51 (1.24–1.92)c < 0.001
PLR 140.26 (107.11–182.96)a 113.03(90.98–143.81)b 94.55 (76.62–116.42)c < 0.001
  1. WBC white blood cells, Hb hemoglobin, MPV mean platelet volume, MPV/PC the ratio between MPV and platelet count, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio
  2. aColorectal cancer group vs. adenomatous polyp group (p < 0.05)
  3. bAdenomatous polyp group vs. control group (p < 0.05)
  4. cColorectal cancer group vs. control group (p < 0.05)
\